Results 161 to 170 of about 10,285,166 (306)

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach, Gizem Abaci, Tom Huberty, Axel Lechner, Lukas Käsmann, Jens Ricke, Sophia Stöcklein, Martin Canis, Philipp Baumeister, Marianna Alunni‐Fabbroni   +9 more
wiley   +1 more source

Quiet eye and motor performance: The longer the better?

, 2017
In targeting tasks, the final fixation duration before movement initiation (i.e., Quiet Eye, QE) has been shown to be a valid predictor of the subsequent motor performance.
Hossner, Ernst-Joachim
core  

NIOSH Center for Motor Vehicle Safety : performance measures : evaluation of strategic plan for research and prevention

The NIOSH Center for Motor Vehicle Safety Strategic Plan for Research and Prevention, 2014-2018 set performance measures for each of the Center for Motor Vehicle Safety\u2019s (CMVS) 5 strategic goals.

core   +1 more source

Increased corticospinal excitability after rest with short term motor performance. [PDF]

Exp Physiol
McCallion Q, Clark AR, Barry BS, Duchow EE, Poston B, Riley ZA.   +5 more
europepmc   +1 more source

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

Molecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang, Hyung Seok Kim, Geum Ok Baek, Moon Gyeong Yoon, Su In Lee, Jee‐Yeong Jeong, Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun   +9 more
wiley   +1 more source

Neurocognitive and Motor Performance in Pediatric Kidney Transplant Recipients: A Cross-Sectional Controlled Study. [PDF]

Children (Basel)
Tirpanci S, Kaya M, Ucgun H, Tasdemir M, Denizoglu Kulli H, Ozkaya O.   +5 more
europepmc   +1 more source

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

Molecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche, Niels J. van Ruitenbeek, Charlotte Adang, Luke O'Gorman, Pui Yuen Lee, Willemijn M. Klein, Adriana C. H. van Engen‐van Grunsven, Jack A. Schalken, Sander Bervoets, Gerald W. Verhaegh, Carla M. L. van Herpen   +10 more
wiley   +1 more source

Differential effects of static and dynamic visual prompts on attention-motor performance: the role of sustained attention after stroke. [PDF]

Front Neurol
Zhang Y, Fan W, Li Y, Zhang J, Chai G, Tang M, Wang L, Xu J.   +7 more
europepmc   +1 more source

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

Molecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi, Tuan Khang Huynh, Adway Kadam, Zahra Kardan, Yue Yan, Amina Jamal Laham, Sampath Kumar Loganathan   +6 more
wiley   +1 more source

A pilot study on the effects of a physio-avatar EB experience on motor performance. [PDF]

Front Bioeng Biotechnol
Kojima R, Matsui K, Okada K, Fujii R, Atsuumi K, Mori Y, Hirai H, Nishikawa A.   +7 more
europepmc   +1 more source